Electrophysiological properties of the propafenone-analogue GE 68 (1-[3-(phenylethyl)-2-benzofuryl]-2-(propylamino)-ethanol) in isolated preparations and ventricular myocytes of guinea-pig hearts

GE 68 ((Rac.)-1-[3-(Phenylethyl)-2-benzofuryl]-2-(propylamino)-ethanol hydrochloride) is structurally related to propafenone, and exerts negative inotropic and negative chronotropic effects similar to the parent drug, but lacks any β-adrenoceptor blocking activity contrary to propafenone. Thus, the electrophysiological effects of GE 68 were studied in papillary muscles, left atria, Purkinje fibres, sinoatrial nodes and ventricular myocytes of the guinea-pig heart with the intracellular microelectrode technique and the patch-clamp technique in the cell-attached mode. The decrease of the maximum upstroke velocity (V˙_max) by GE 68 (1 to 10 μM) was use- and frequency-dependent. V˙_max recovered from the use-dependent block with a time constant of 4.1 ± 0.6 s. In papillary muscles and Purkinje fibres action potential duration was shortened, while it was prolonged in left atria and sinoatrial nodes. Half-maximal steady-state inactivation of the sodium channels was shifted to more negative membrane potentials (control: –91.5 ± 0.8 mV, 10 μM GE 68: –97.9 ± 2.5 mV). The peak of the current-voltage relationship and the reversal potential were not changed by GE 68. The amplitude of the unitary current remained unaltered, while open state probability was decreased. The most striking effect of GE 68 was an increase of the number of sweeps without single channel openings (1 μM: 2 fold, 10 μM: 6 fold). GE 68 also caused a decrease of the mean open times, and an increase of the mean closed times in unmodified and pronase-modified sodium channels. Besides the lack of β-adrenoceptor blocking activity, data present a faster recovery from the use-dependent block by GE 68 and a lower affinity to inactivated sodium channels compared to the reference drug propafenone, as well as differences in the effect on single channel kinetics. Received: 25 July 1996 / Accepted: 14 October 1996     

Pharmacology of KB‐R7943: A Na+–Ca2+ exchange inhibitor

The Na⁺–Ca²⁺ exchange (NCX) system plays a pivotal role in regulating intracellular Ca²⁺ concentration in cardiomyocytes, neuronal cells, kidney and a variety of other cells. It performs a particularly important function in regulating cardiac contractility and electrical activity. One of the leading NCX inhibitors is KB‐R9743 (KBR) that appears to exhibit selectivity for Ca²⁺‐influx‐mode NCX activity (reverse mode of NCX). In this article we reviewed pharmacology of KBR and provide a brief summary of studies with other NCX inhibitors, such as SEA0400 (SEA) and SN‐6 (SN). Potential clinical usefulness of KBR and other NCX inhibitors is still controversial but the reviewed findings may be helpful in designing more selective and clinically useful NCX inhibitors for the treatment of cardiac, neuronal and kidney diseases.     

Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmakalim

Adenosine triphosphate (ATP) dependent potassium channels (K_ATP channels) in heart ventricular muscle cells can be activated by depletion of intracellular ATP stores as well as by channel openers. In the present study we examined whether properties of K_ATP channels are dependent on the mode of activation. Whole-cell and single-channel currents were investigated by use of the patch-clamp technique in isolated ventricular rat myocytes. The channel opener rilmakalim dose dependency activated whole-cell currents [concentration for half-maximal activation (EC₅₀) = 1.1 M, Hill coefficient = 3.1, saturation concentration 10 M]. Metabolic inhibition with 2-deoxy-d-glucose (10 mmol/l) also activated K_ATP currents after a time lag of several minutes. These currents were about two-fold higher than the rilmakalim-activated currents (rilmakalim-activated current 3.9 ±0.2nA, 2-deoxy-d-glucose-activated current 8.1±0.9 nA; both recorded at 0 mV clamp potential). While the rilmakalim-activated current could be blocked completely and with high affinity by the sulphonylurea glibenclamide [concentration for half-maximal inhibition (IC₅₀) = 8 nM, Hill coefficient = 0.7] the 2-deoxy-d-glucose-activated current could only be blocked partially (by maximally 46%) and higher glibenclamide concentrations were needed (IC₅₀ = 480 nM, Hill coefficient = 0.8). The partial loss of blocking efficiency after metabolic inhibition was not restricted to glibenclamide but was also observed with the sulfonylureas glimepiride and HB 985, as well as with the non-sulfonylureas HOE 511 and 5-hydroxydecanoate. Single-channel studies were in accordance with these whole-cell experiments. Both rilmakalim and metabolic inhibition with the uncoupler carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) activated single channels in the attached mode, where the number of current levels was significantly higher in the case of FCCP. Rilmakalim-activated channels were completely blocked by 10 M glibenclamide, whereas several single-channel levels appeared in the presence of 100 M glibenclamide after metabolic inhibition. In conclusion, after metabolic inhibition the amplitude of the activated K_ATP current is about twice as high as under saturating concentrations of the opener rilmakalim. Moreover, channels activated by metabolic inhibition lost part of their sensitivity to known channel blockers.     

miR-139-3p在低氧诱导凋亡的心肌细胞中的表达及其作用研究

目的:探讨微小RNA-139-3p(miR-139-3p)在低氧诱导的原代心肌细胞凋亡模型中的表达及其意义。方法:在正常和低氧条件下,采用RT-qPCR检测乳大鼠原代心肌细胞miR-139-3p的表达水平;进一步将miR-139-3p抑制剂和miR-139-3p抑制剂阴性对照转染到心肌细胞后,将细胞置于37℃密闭的缺氧盒中(95%N_2和5%CO_2)培养12 h,采用流式细胞术和Western blot法检测细胞凋亡情况。结果:低氧培养12 h后,与正常培养组(n=3)比较,低氧组(n=3)心肌细胞中的miR-139-3p相对表达量显著上调(P0.05)。低氧组心肌细胞凋亡率也显著升高(P0.05)。与miR-139-3p抑制剂阴性对照组(n=3)比较,miR-139-3p抑制剂组(n=3)的心肌细胞凋亡率显著降低(P0.05)。结论:miR-139-3p在低氧诱导的原代心肌细胞凋亡模型中表达上调。抑制miR-139-3p的表达能降低低氧诱导的心肌细胞凋亡。     

神经生长因子诱导后的交感神经元样PC12细胞与新生大鼠心肌细胞共培养的实验研究

探讨神经生长因子(NGF)诱导的交感神经元样PC12细胞作为体外再造心肌神经支配研究模型的可行性。用含0.04?TA的0.25%胰酶分离新生大鼠原代心肌细胞,然后与NGF诱导的交感神经元样PC12细胞共培养,通过光学显微镜观察、常规H.E.染色、激光共聚焦显微镜和扫描电镜观察等对其进行评价。结果表明:在二维共培养模型中,NGF诱导的交感神经元样PC12细胞长出神经突起,突起及其上的膨体能够到达跳动的心肌细胞表面,神经突起随心肌细胞一起跳动。采用神经元样PC12细胞作为体外再造心肌神经支配研究模型是可行的,神经细胞与心肌细胞可能存在支配关系。     

人类胚胎生殖细胞体外分化为心肌细胞的研究

胚胎生殖（EG）细胞是来源于胚胎原始生殖细胞（PGCs）的多潜能干细胞。采用无饲养层细胞、无细胞因子等的基础培养液（DMEM＋20％NBS＋0．1mM 2Me）培养EG细胞，部分在基础培养液添加10μmol／LRA＋0．75％DMSO或10μmol／L 5-氮胞苷（5-AZA）诱导人类EG细胞向心肌细胞分化，以检测其是否具有向心肌细胞自发分化的能力。9例（8．49％，9／106）胎儿EG细胞在体外分化得到20个节律性心脏跳动样细胞团，其搏动节律为20～120次／min，体外维持节律性搏动最短2d，最长至15d，呈PAS，Myoglobin，α-actin阳性；对K^＋、Ca^＋、肾上腺素等具有与在体心脏相似的反应性；透射电镜观察具有心肌细胞样结构。添加DMSO和RA或5-AZA诱导未得到跳动样心肌细胞，但可提高心肌α-actin免疫组织化学染色阳性率；表明人类胚胎生殖细胞具有向心肌细胞分化的潜能。     

心肌肽素对豚鼠心室肌细胞钠通道的影响

目的： 研究心肌肽素对豚鼠心室肌细胞钠通道的影响，探讨心肌肽素在离子通道水平的作用机制。 方法： 用急性酶解分离法获得豚鼠心室肌细胞，标准全细胞膜片钳技术记录钠电流(I_Na)。 结果： 心肌肽素1、5、10、50、100、500 mg/L使豚鼠心室肌细胞I_Na分别减少(0±1)%、(6±2)%、(10±2)%、(15±1)%、(22±9)%、(30±6)%，呈浓度依赖性抑制I_Na。心肌肽素50 mg/L使I_Na激活时间(TTP)从(2.8±0.7) ms延长至(3.0±0.8) ms (P<0.05)；使I_Na电流密度-电压曲线上移，但不改变激活电位、峰电位、反转电位和I-V曲线的形状；不影响稳态激活曲线、稳态失活曲线和稳态失活后恢复曲线。 结论： 心肌肽素浓度依赖性抑制豚鼠心室肌细胞I_Na，可能是其抗心律失常作用的机制之一。     

Decay-accelerating factor in the cardiomyocytes of normal individuals and patients with myocardial infarction

Summary The presence of decay-accelerating factor (DAF) was clearly demonstrated on the surface of normal cardiomyocytes. In patients who had died of myocardial infarction (MI) cardiomyocytes displayed different appearances: outside the ischaemically damaged region the myocytes showed no significant variations in DAF expression when compared with controls without MI. Within myocardial zones damaged by ischaemia, however, apparently normal myocytes showed large gaps in surface staining of DAF or formed clusters which were entirely devoid of reactivity with anti-DAF antibodies. The number of DAF-deficient myocytes increased with the extent of necrosis and also with the number of days between onset of MI and death. Even though injury to myocytes is to a large extent related to anoxia and to the presence of free oxygen radicals, the complement system also appears to be involved; DAF may have protective functions against complement-mediated injury. We speculate that phospholipase may be involved in the removal of DAF from the cardiomyocyte surface.This work was supported in part by grant no. 3.157.88 from the Swiss National Foundation for Scientific Research and a contribution from Sandoz Ltd. Pharma Division, Basel     

Pharmacological characterization of A1 adenosine receptors in isolated rat ventricular myocytes

Summary The aim of the present study was the characterization of adenosine receptors in isolated rat ventricular myocytes. The CAMP-levels of rat ventricular myocytes in the presence of 1 mol/l isoprenaline were reduced by up to 48% by adenosine analogues; the rank order of potency was: R-N⁶-phenylisopropyladenosine (IC₅₀ 60 nmol/1), 5-N-ethylcarboxamidoadenosine (IC₅₀ 360 nmol/l) and S-N⁶-phenylisopropyladenosine (IC₅₀ 16 ol/l). The adenosine receptor antagonist XAC (xanthine amine congener) antagonized the effect of R-N⁶-phenylisopropyladenosine in a concentration-dependent manner with a K_i-value of 20 nmol/l. The A₁ receptor-selective radioligand R-N⁶-¹²⁵I-p-hydroxyphenylisopropyladenosine bound to membranes prepared from rat ventricular myocytes in a saturable manner with a B _max of 17.7 fmol/mg protein and a K _D-value of 1.1 nmol/l. Adenosine analogues competed for the binding with the same rank order of potency as for the inhibition of the isoprenaline-induced cAMP-increase. GTP inhibited radioligand binding with an IC₅₀-value of 73 ol/l. These results suggest the presence of A₁ adenosine receptors on rat ventricular myocytes, which mediate an inhibition of adenylate cyclase. The receptors may be responsible for the effects of adenosine and its analogues on the heart.Abbreviations ¹²⁵I-HPIA R-N⁶-¹²⁵I-p-hydroxyphenylisopropyladenosine - PIA N⁶-phenylisopropyladenosine - NECA 5-N-ethyl-carboxamidoadenosine - XAC 8-4-[([(2-aminoethyl)aminocarbonyl]methyl)oxy]phenyl-1,3-dipropylxanthine (xanthine amine congener) - Ro 20-1724 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone - ScAMPTME 2-O-monosuccinyladenosine-3,5-cyclic monophosphate tyrosyl methyl ester - HEPES N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid - GTP guanosine-5-tri-phosphate Send offprint requests to D. Martens     

人诱导多能干细胞分化来源心肌细胞特征及促成熟方法研究进展

人诱导多能干细胞分化来源的心肌细胞(Human induced pluripotent stem cells-derived cardiomyocytes,hiPSC-CMs)为心脏修复、心脏药物测试、体外心脏建模等提供了理想细胞来源。但hiPSC-CMs与心肌细胞相比并不成熟,表现在缺乏某些特定基因表达,结构、代谢、电生理不成熟,Ca 2+处理水平低等方面。许多研究都聚焦于促进hiPSC-CMs成熟的方法,包括生化刺激、物理刺激、共培养、3D培养、miRNA等。本文对hiPSC-CMs特征及其促成熟方法进行综述,并展望该领域的发展方向。